The Cost to Medicare of Bladder Cancer Care

Slides:



Advertisements
Similar presentations
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Advertisements

Testosterone Therapy in Men With Prostate Cancer
Volume 66, Issue 6, Pages (December 2014)
European Urology Oncology
Volume 73, Issue 1, Pages (January 2018)
Volume 64, Issue 4, Pages (October 2013)
Yair Lotan, Peter C. Black, Laura Caba, Sam S. Chang, Michael S
Volume 72, Issue 5, Pages (November 2017)
Prostate Cancer Epidemic in Sight?
European Urology Oncology
European Urology Oncology
Bladder Cancer: A Major Public Health Issue
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
European Urology Oncology
Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis  Mohamad B. Sonbol, Belal Firwana, Talal.
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 69, Issue 3, Pages (March 2016)
European Urology Oncology
European Urology Oncology
Counselling the Prostate Cancer Patient
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
Prostate Cancer Epidemic in Sight?
Stephen B. Williams, Ashish M
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 6, Pages (December 2014)
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
European Urology Oncology
Role of Checkpoint Inhibition in Localized Bladder Cancer
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
European Urology Oncology
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA  Nawar Hanna, Quoc-Dien Trinh,
Testicular Cancer Variations in Time and Space in Europe
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
European Urology Oncology
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
European Urology Oncology
European Urology Oncology
Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder  Devin N. Patel, Michael Luu, Zachary.
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review  Alexey Surov, Hans Jonas Meyer, Andreas.
European Urology Oncology
Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis  Joseph Sargon Joseph, Vincent.
European Urology Oncology
European Urology Oncology
Economic Burden of Bladder Cancer Across the European Union
European Urology Oncology
European Urology Oncology
European Urology Oncology
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
European Lung Cancer Conference (ELCC) 2016 Organisation
Volume 54, Issue 1, Pages (July 2008)
European Urology Oncology
European Urology Oncology
European Urology Oncology
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
European Urology Oncology
Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood  Jan F.M. Verbeek,
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
Presentation transcript:

The Cost to Medicare of Bladder Cancer Care Frank A. Sloan, Arseniy P. Yashkin, Igor Akushevich, Brant A. Inman  European Urology Oncology  DOI: 10.1016/j.euo.2019.01.015 Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 1 Differences in Medicare monthly real payments per person: persons with bladder cancer versus controls at (A) all stages and (B) localized stage. Solid lines represent full sample and dotted lines represent 16-yrs survivors. European Urology Oncology DOI: (10.1016/j.euo.2019.01.015) Copyright © 2019 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.